Skip to content

Early recognition of heart failure in patients with diabetes type 2 in primary care.

Early recognition of heart failure in patients with diabetes type 2 in primary care. - Heart failure in diabetes (UHFO-DM)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32109
Enrollment
600
Registered
2008-12-02
Start date
2009-02-07
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Patients (men or women) with diabetes type 2 -Enlisted with the diabetes service of the Diagnostic Center in Etten-Leur (SHL) -Age 60 years or older

Exclusion criteria

Exclusion criteria: Those with a cardiologist-confirmed (and thus known with a) diagnosis of heart failure. The latter group will not be invited for the diagnostic assessment at the cardiology outpatient clinic, to prevent them from redundant investigations. Moreover, by adding up the prevalence of those already known with heart failure with the prevalence rate of newly detected (previously unknown) heart failure patients after the diagnostic assessment provides the overall prevalence of heart failure in patients with diabetes aged 60 years and over. Thus, the overall prevalence rate of heart failure (known plus newly detected) can be calculated without diagnostic assessment of those with diabetes already known with established heart failure. This group will be asked to answer the Quality of Life questionnairres.

Design outcomes

Primary

MeasureTime frame
Prevalence (with exact 95% confidence intervals) of (unrecognised) heart failure (systolic and 'isolated' diastolic) and diagnostic value of signs and symptoms (including co-morbidity), NT-proBNP, ECG and a combination of these items. Moreover, the cost-effectiveness of the different diagnostic strategies.

Secondary

MeasureTime frame
Impact of heart failure, and the combination of diagnosis and treatment of heart failure, on health related quality of life in patients with type 2 diabetes.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)